RAC Devices Verified Multiple Choice and
Conceptual Actual Frequently Tested Exam
Questions With Reviewed 100%
Correct Detailed Answers
Guaranteed Pass!!Current Update!!
1. Which of the following is a primary regulatory body for medical devices in the
United States?
A) European Medicines Agency (EMA)
B) Medicines and Healthcare products Regulatory Agency (MHRA)
C) Food and Drug Administration (FDA)
D) Therapeutic Goods Administration (TGA) - ANSWER C) Food and Drug
Administration
2. Which document is required for a PMA (Premarket Approval) submission?
- A) Device Master Record (DMR)
- B) Clinical evaluation report
- C) 510(k) submission letter
- D) Declaration of Conformity - ANSWER B) Clinical Evaluation Report
,The Clinical Evaluation Report is a crucial document required for PMA submissions
as it provides detailed information about the clinical trials and studies conducted
to demonstrate the safety and effectiveness of the device. This report includes
data from clinical studies and serves as a key component in the PMA submission
process to obtain FDA approval.
3. What is the primary purpose of post-market surveillance?
A) To validate the initial clinical trial results
B) To monitor device performance and safety after it is on the market
C) To submit new device design specifications
D) To secure intellectual property rights - ANSWER B) To monitor device
performance and safety after it is on the market
Post-market surveillance involves ongoing monitoring of a device's performance
and safety once it is available to the public. This process helps identify any
potential issues that were not apparent during clinical trials and ensures that the
device continues to meet safety and effectiveness standards throughout its
lifecycle.
4. Which of the following is considered a Class II medical device?
A) Surgical gloves
B) Infusion pump
C) Heart valve
D) Bandages - ANSWER B) Infusion pump
Here's a brief overview of the classifications for the given devices:
,A) Surgical gloves: Typically classified as Class I (low risk).
B) Infusion pump: Considered Class II (moderate risk) due to its need for special
controls to ensure safety and effectiveness.
C) Heart valve: Generally classified as Class III (high risk) due to the critical nature
of its use and the need for rigorous clinical evidence.
D) Bandages: Typically classified as Class I (low risk).
5. The European Union's Medical Device Regulation (MDR) replaced which
previous directive?
A) Medical Device Directive (MDD)
B) In Vitro Diagnostic Device Directive (IVDD)
C) Active Implantable Medical Devices Directive (AIMDD)
D) General Safety Directive (GSD) - ANSWER A) MDD
The MDR (EU) 2017/745 replaced the Medical Device Directive (MDD)
(93/42/EEC) and introduced more stringent regulatory requirements for medical
devices within the EU. The In Vitro Diagnostic Device Regulation (IVDR) (EU)
2017/746 replaced the In Vitro Diagnostic Device Directive (IVDD) (98/79/EC), and
the Active Implantable Medical Devices Directive (AIMDD) (90/385/EEC) was also
replaced by the MDR. The General Safety Directive (GSD) is not related to medical
devices.
6. What does the term "substantial equivalence" refer to in a 510(k) submission?
A) Demonstrating that a device is identical to a marketed device
B) Showing that a device performs as intended without significant risks
, C) Proving that a device is equivalent in safety and effectiveness to a legally
marketed device
D) Establishing that a device meets international quality standards - ANSWER
C) Proving that a device is equivalent in safety and effectiveness to a legally
marketed device
Substantial equivalence means that the new device is as safe and effective as a
predicate device that is already legally marketed. The manufacturer must
demonstrate that the new device is comparable to the predicate in terms of
intended use, technological characteristics, and performance.
7. What is the main purpose of the Device History Record (DHR)?
A) To document the design and development of the device
B) To record the production and quality control history of each device
C) To provide clinical trial results
D) To manage post-market surveillance data - ANSWER B) To record the
production and quality control history of each device
The DHR is a comprehensive record that documents all activities related to the
manufacturing and quality control processes for each specific device. It includes
details such as production dates, lot or batch numbers, inspections, and any
deviations from the standard processes. The DHR ensures that each device has
been manufactured according to the required specifications and quality
standards.
8. Which of the following is a requirement for clinical evaluations under the
MDR?
Conceptual Actual Frequently Tested Exam
Questions With Reviewed 100%
Correct Detailed Answers
Guaranteed Pass!!Current Update!!
1. Which of the following is a primary regulatory body for medical devices in the
United States?
A) European Medicines Agency (EMA)
B) Medicines and Healthcare products Regulatory Agency (MHRA)
C) Food and Drug Administration (FDA)
D) Therapeutic Goods Administration (TGA) - ANSWER C) Food and Drug
Administration
2. Which document is required for a PMA (Premarket Approval) submission?
- A) Device Master Record (DMR)
- B) Clinical evaluation report
- C) 510(k) submission letter
- D) Declaration of Conformity - ANSWER B) Clinical Evaluation Report
,The Clinical Evaluation Report is a crucial document required for PMA submissions
as it provides detailed information about the clinical trials and studies conducted
to demonstrate the safety and effectiveness of the device. This report includes
data from clinical studies and serves as a key component in the PMA submission
process to obtain FDA approval.
3. What is the primary purpose of post-market surveillance?
A) To validate the initial clinical trial results
B) To monitor device performance and safety after it is on the market
C) To submit new device design specifications
D) To secure intellectual property rights - ANSWER B) To monitor device
performance and safety after it is on the market
Post-market surveillance involves ongoing monitoring of a device's performance
and safety once it is available to the public. This process helps identify any
potential issues that were not apparent during clinical trials and ensures that the
device continues to meet safety and effectiveness standards throughout its
lifecycle.
4. Which of the following is considered a Class II medical device?
A) Surgical gloves
B) Infusion pump
C) Heart valve
D) Bandages - ANSWER B) Infusion pump
Here's a brief overview of the classifications for the given devices:
,A) Surgical gloves: Typically classified as Class I (low risk).
B) Infusion pump: Considered Class II (moderate risk) due to its need for special
controls to ensure safety and effectiveness.
C) Heart valve: Generally classified as Class III (high risk) due to the critical nature
of its use and the need for rigorous clinical evidence.
D) Bandages: Typically classified as Class I (low risk).
5. The European Union's Medical Device Regulation (MDR) replaced which
previous directive?
A) Medical Device Directive (MDD)
B) In Vitro Diagnostic Device Directive (IVDD)
C) Active Implantable Medical Devices Directive (AIMDD)
D) General Safety Directive (GSD) - ANSWER A) MDD
The MDR (EU) 2017/745 replaced the Medical Device Directive (MDD)
(93/42/EEC) and introduced more stringent regulatory requirements for medical
devices within the EU. The In Vitro Diagnostic Device Regulation (IVDR) (EU)
2017/746 replaced the In Vitro Diagnostic Device Directive (IVDD) (98/79/EC), and
the Active Implantable Medical Devices Directive (AIMDD) (90/385/EEC) was also
replaced by the MDR. The General Safety Directive (GSD) is not related to medical
devices.
6. What does the term "substantial equivalence" refer to in a 510(k) submission?
A) Demonstrating that a device is identical to a marketed device
B) Showing that a device performs as intended without significant risks
, C) Proving that a device is equivalent in safety and effectiveness to a legally
marketed device
D) Establishing that a device meets international quality standards - ANSWER
C) Proving that a device is equivalent in safety and effectiveness to a legally
marketed device
Substantial equivalence means that the new device is as safe and effective as a
predicate device that is already legally marketed. The manufacturer must
demonstrate that the new device is comparable to the predicate in terms of
intended use, technological characteristics, and performance.
7. What is the main purpose of the Device History Record (DHR)?
A) To document the design and development of the device
B) To record the production and quality control history of each device
C) To provide clinical trial results
D) To manage post-market surveillance data - ANSWER B) To record the
production and quality control history of each device
The DHR is a comprehensive record that documents all activities related to the
manufacturing and quality control processes for each specific device. It includes
details such as production dates, lot or batch numbers, inspections, and any
deviations from the standard processes. The DHR ensures that each device has
been manufactured according to the required specifications and quality
standards.
8. Which of the following is a requirement for clinical evaluations under the
MDR?
